• Skip to main content
  • Main Menu
  • Navigation for access to support pages
  • Navigation for access to legal pages
 Logo Viva Technology
  • Session Recordings
  • Speakers
  • Exhibitors
  • FAQ
  • General Public Day
  • confirmation_numberGet Your 2026 Pass
  • Become an Exhibitor
  1.  Logo Viva Technology
  2. Sessions
  3. 2025-06-12
Official Program
Partners’ Program
 Viva Technology

17-20 June 2026

Paris Expo Porte de Versailles

1 Place de la Porte de Versailles

F-75015 Paris France

More Infoarrow_right_alt

Event organizers

2025 ThemesConference ProgramOur Speakers

Exhibitors at VivaTech2025 Partners

Startups at VivaTechInvestors at VivaTech2025 Startup Challenges and Awards

JournalistsMedia Partners2025 PresskitPress Releases

About UsOur CommitmentsGeneral Public DayPractical Information

©Viva Technology 2016-2025 all rights reserved

Site MapSite noticeWebsite terms & conditionsB2B terms & conditionsData Privacy

Conference Program


Our program is currently a work in process and will be updated regularly in the upcoming weeks leading up to this year's edition.
11 June12 June13 June14 June

The Rise of Sovereign Scientific AI

As organizations (and nations) seek greater control over their AI technologies and research processes, the concept of "sovereign scientific AI" has emerged, questionning the possibility of developping robust, independent AI capabilities for scientific discovery while maintaining appropriate control over data, infrastructure and IP in their development strategy.

AI Drug Discovery: Curing with Code

As AI systems grow more capable in modeling complex biological systems, drug discovery is entering a new era — one where machine learning models don't just assist researchers, but actively generate hypotheses, design molecules, and predict therapeutic outcomes. This session explores the shift from traditional trial-and-error approaches to AI-driven methodologies that can integrate biological data at unprecedented scale and speed. What does it mean to have AI as a true collaborator in science? Can these systems unlock treatments for diseases that have eluded medicine for decades? As AI takes on a greater role in healthcare decision-making, how do we ensure that its use remains transparent, equitable, and ethically sound?